ALT
Altimmune, Inc.
6.52
-
0.18
2.69%
1 x 6.49
3 x 6.52
bid
ask
10:18 AM
timesize
Bearish
41
Bullish
103
sentiment
6.49
day range
6.76
2.14
52 week range
13.81
Prev Close6.70
Open6.67
Low6.49
High6.76
Volume293.26K
Avg. Volume3.35M
Market Cap462.67M
Inst. Own60.88%
Beta0.07
Short Ratio8.78
Div & Yield0.00 /
EPS-1.63
P/E0.00
1yr Target20.57
50day MA6.68
200day MA7.82
CNQ.TO
Canadian Natural Resources Limited
47.01
10:18 AM
-
1.77
3.63%
G.TO
Augusta Gold Corp.
0.77
10:13 AM
+
0.00
0.00%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.12
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2341.30
05:59 AM
+
5.15
0.22%
600690.SS
Haier Smart Home Co., Ltd.
25.18
03:00 AM
+
0.76
3.11%
0700.HK
Tencent Holdings Limited
378.20
04:08 AM
+
0.40
0.11%
1101.TW
TCC Group Holdings Co., Ltd.
32.15
01:30 AM
-
0.60
1.83%
20MICRONS.NS
20 Microns Limited
315.20
05:59 AM
-
3.30
1.04%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Profile
...
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -0.34 | -0.35 | -0.01 | -2.94% |
2024-05-09 | 2024-03 | -0.36 | -0.34 | 0.02 | 5.56% |
2024-03-27 | 2023-12 | -0.35 | -0.33 | 0.02 | 5.71% |
2023-11-07 | 2023-09 | -0.4 | -0.39 | 0.01 | 2.50% |
2023-08-10 | 2023-06 | -0.44 | -0.32 | 0.12 | 27.27% |
2023-05-11 | 2023-03 | -0.49 | -0.4 | 0.09 | 18.37% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-10 | B. Riley Securities | Upgrade | Buy | Buy |
2023-07-11 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
2023-05-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-03-30 | JMP Securities | Upgrade | Market Outperform | |
2023-03-21 | JMP Securities | Upgrade | Market Outperform |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-08-18 | DRUTZ DAVID J | Director | 0.00 | Sale |
2024-01-30 | EISENSTADT RICHARD I | Chief Financial Officer | 45.01K | Stock Award(Grant) |
2024-02-01 | GARG VIPIN K. | Chief Executive Officer | 292.03K | Conversion of Exercise of derivative security |
2022-08-11 | GILL JOHN M | Director | 2.77K | Sale |
2024-07-30 | HARRIS MATTHEW SCOTT | Officer | 55.12K | Stock Award(Grant) |
2024-07-30 | JORDT RAYMOND M | Officer | 14.66K | Stock Award(Grant) |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 3.66M | 12.93M | 6.95% |
2023-06-29 | Nuveen Asset Management, LLC | 3.46M | 12.21M | 6.57% |
2023-06-29 | Vanguard Group Inc | 3.31M | 11.67M | 6.27% |
2023-06-29 | Tang Capital Management, LLC | 2.75M | 9.71M | 5.22% |
2023-06-29 | Marshall Wace LLP | 2.06M | 7.27M | 3.91% |
2023-06-29 | Laurion Capital Management, LP | 1.84M | 6.49M | 3.49% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | College Retirement Equities Fund-Stock Account | 2.00M | 7.05M | 3.79% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.62M | 5.71M | 3.07% |
2023-06-29 | College Retirement Equities Fund-Global Equities Account | 1.27M | 4.48M | 2.41% |
2023-08-30 | iShares Russell 2000 ETF | 1.18M | 3.00M | 2.25% |
2023-06-29 | Vanguard Extended Market Index Fund | 621.63K | 2.19M | 1.18% |
2023-06-29 | Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 490.56K | 1.73M | 0.93% |
Dividend
...
Dividend | Date |
---|---|
291 | 2017-02-07 |
2.91 | 2017-02-06 |
291.003 | 2017-01-20 |
Split
...
Split | Date |
---|---|
1 : 30 | 2018-09-14 |
10 : 1 | 2017-05-05 |
This topic has been deleted. Only users with topic management privileges can see it.
-
-
Back up we go!
-
Come on deep pockets!
-
Big mistake selling your position this Friday! Just saying
-
News or not? Why the bump?
-
If partner and funding news gets released at the same time, we will go to the moon.
-
Funny all the people trying to take credit for cv play. Lmao, probably have something to do with it???
-
There goes premarket again
-
News announced?
-
Lol it’s happening again
-
3700 at 2.62 here...
-
AH. close in green
-
Price isn’t going anywhere
-
Futures down another 900 points, if that gets worse we will fly tomorrow. If you haven’t been noticing the trend.
-
Exceeded my expectations
-
What about nasovax? News?
-
Anything spurring this small run up?
-
PH and AH is going to be sweet
-
Looks like we have a new bottom
-
Link for buy out?
-
Altimmune: Emerging Position In Competitive Space, But Risks Remain
seekingalpha.com • -
ALT5 Sigma Appoints Peter Tassiopoulos as Chief Executive Officer
accesswire.com • -
ALT 5 Sigma to Exhibit at SiGMA Budapest September 2-4, 2024
accesswire.com • -
ALT5 Sigma Reports Fiscal Financial Results for Second Quarter 2024
accesswire.com • -
3 Promising Biotech Stocks for the Long-Term: August 2024
investorplace.com • -
The 7 Best Under $10 Stocks to Buy in August 2024
investorplace.com • -
Altimmune, Inc. (ALT) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
3 Undervalued Biotech Stocks With Breakout Potential
investorplace.com • -
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
investorplace.com • -
7 Bullish Stock Picks With the Potential to Turn $5K Into $50K
investorplace.com •